A systematic review and meta-analysis of prospective studies investigating adiponectin and the risk for incident coronary heart disease (CHD) or stroke comprising 23,919 patients concluded that plasma adiponectin is not related to the risk for incident CHD or stroke [10]. The gene discussed is ADIPOQ; the disease is coronary artery disorder.